Susquehanna International Group, LLP Co Diagnostics, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 213,316 shares of CODX stock, worth $53,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,316

Previous 259,125 17.68%

Holding current value

$53,329

Previous $194,000 65.98%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.31 - $1.0 $14,200 - $45,809	-45,809 Reduced 17.68%	213,316 $66,000
Q4 2024 Feb 14, 2025	BUY	$0.7 - $1.36 $50,089 - $97,316	71,556 Added 38.15%	259,125 $194,000
Q3 2024 Nov 14, 2024	SELL	$1.02 - $1.75 $14,281 - $24,501	-14,001 Reduced 6.95%	187,569 $234,000
Q2 2024 Aug 15, 2024	BUY	$1.01 - $1.7 $107,976 - $181,741	106,907 Added 112.93%	201,570 $251,000
Q1 2024 May 07, 2024	SELL	$1.06 - $1.42 $13,818 - $18,511	-13,036 Reduced 12.1%	94,663 $106,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.5 $26,414 - $39,621	26,414 Added 32.5%	107,699 $143,000
Q3 2023 Nov 14, 2023	BUY	$1.03 - $1.85 $46,272 - $83,111	44,925 Added 123.56%	81,285 $86,000
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.64 $3,637 - $5,736	3,498 Added 10.64%	36,360 $40,000
Q1 2023 May 16, 2023	SELL	$1.39 - $3.24 $132,432 - $308,691	-95,275 Reduced 74.35%	32,862 $48,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $72,843 - $115,544	-31,398 Reduced 19.68%	128,137 $322,000
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $328,244 - $801,740	114,371 Added 253.23%	159,535 $512,000
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $217,474 - $363,807	-57,839 Reduced 56.15%	45,164 $253,000
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $1.41 Million - $2.7 Million	-280,569 Reduced 73.15%	103,003 $637,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $328,153 - $419,082	-40,413 Reduced 9.53%	383,572 $3.43 Million
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $1.73 Million - $2.64 Million	231,560 Added 120.34%	423,985 $4.13 Million
Q2 2021 Aug 11, 2021	SELL	$7.16 - $9.56 $139,691 - $186,515	-19,510 Reduced 9.21%	192,425 $1.59 Million
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $1.7 Million - $3.82 Million	198,977 Added 1535.55%	211,935 $2.02 Million
Q4 2020 Feb 16, 2021	SELL	$9.3 - $15.19 $2.5 Million - $4.08 Million	-268,809 Reduced 95.4%	12,958 $121,000
Q3 2020 Nov 16, 2020	BUY	$8.24 - $30.8 $1.12 Million - $4.2 Million	136,405 Added 93.84%	281,767 $3.83 Million
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $701,993 - $2.2 Million	94,101 Added 183.57%	145,362 $2.81 Million
Q1 2020 May 15, 2020	BUY	$0.91 - $17.81 $46,647 - $912,958	51,261 New	51,261 $391,000

Others Institutions Holding CODX

# of Institutions

Shares Held

5.71M

Call Options Held

35.6K

Put Options Held

25.9K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $8.45M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Co Diagnostics, Inc. Transaction History